{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:55:55Z","timestamp":1791107755574,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union\u2019s Seventh Framework Programme"},{"name":"Doerenkamp-Zbinden Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.tiv.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T01:56:30Z","timestamp":1415152590000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"PA","title":["Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure"],"prefix":"10.1016","volume":"30","author":[{"given":"Jessica J.W.","family":"Broeders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine L.","family":"Truisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozenn","family":"Joss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille C.","family":"Savary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.H.","family":"van Eijkeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop L.M.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas J.","family":"Blaauboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2014.08.012_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tiv.2009.05.021","article-title":"Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction in freshly isolated cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions","volume":"24","author":"Abadie-Viollon","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.08.012_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.tiv.2014.08.012_b0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/00498254.2012.676693","article-title":"Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers","volume":"42","author":"Alexandre","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2014.08.012_b0020","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2014.08.012_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0030","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Anth\u00e9rieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2014.08.012_b0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.molmed.2003.10.002","article-title":"Molecular aspects of bile formation and cholestasis","volume":"9","author":"Arrese","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tiv.2014.08.012_b0040","unstructured":"Bachour-El Azzi, P., Sharanek, A., Abdel-Razzak, Z., Anth\u00e9rieu, S., Al-Attrache, H., Savary, C., Lepage, S., Morel, I., Labbe, G., Gugen-Guillouzo, C., Guillouzo, A., [Epub ahead of print] Drug Metab. Dipos. 2014 July 7. pii: dmd.114.058123."},{"key":"10.1016\/j.tiv.2014.08.012_b0045","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1124\/dmd.105.009118","article-title":"Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport","volume":"34","author":"Bi","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00117862","article-title":"Relative cytotoxicity of psychotropic drugs in cultured rat hepatocytes","volume":"3","author":"Boelsterli","year":"1987","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0055","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1016\/j.chroma.2011.09.064","article-title":"Development of a negligible depletion-solid phase microextraction method to determine the free concentration of chlorpromazine in aqueous samples containing albumin","volume":"1218","author":"Broeders","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tiv.2014.08.012_b0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2011.05.002","article-title":"Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes","volume":"43","author":"De Bruyn","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2014.08.012_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1389200053586118","article-title":"In vitro methods to study chemically-induced hepatotoxicity: a literature review","volume":"6","author":"Farkas","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2014.08.012_b0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro p-glycoprotein assays to predict the in vivo interactions of p-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0080","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by Hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2014.08.012_b0085","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/17425255.4.10.1279","article-title":"Evolving concepts in liver tissue modeling and implications for in vitro toxicology","volume":"4","author":"Guillouzo","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.08.012_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-2333(01)00008-X","article-title":"Factors influencing nominal effective concentrations of chemical compounds in vitro: cell concentration","volume":"15","author":"G\u00fclden","year":"2001","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.08.012_b0100","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1021\/es049285w","article-title":"Toward more useful in vitro toxicity data with measured free concentrations","volume":"38","author":"Heringa","year":"2004","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2014.08.012_b0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tiv.2014.08.012_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.08.012_b0115","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/dmd.107.019901","article-title":"Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies","volume":"36","author":"Joss\u00e9","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/tx200479k","article-title":"Quantifying the processes that determine the free concentration of phenanthrene in a basal cytotoxicity assay","volume":"25","author":"Kramer","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"287","author":"Lasser","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.tiv.2014.08.012_b0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Le Vee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2014.08.012_b0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-688-7_3","article-title":"Isolation and culture of primary hepatocytes from resected human liver tissue","volume":"640","author":"LeCluyse","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2014.08.012_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4","article-title":"Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes","volume":"14","author":"LeCluyse","year":"2000","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10408444.2012.682115","article-title":"Organotypic liver culture models: meeting current challenges in toxicity testing","volume":"42","author":"LeCluyse","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2007.01.001","article-title":"Human hepatocytes: isolation, cryopreservation and applications in drug development","volume":"168","author":"Li","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.08.012_b0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.tiv.2014.08.012_b0170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ejps.2012.01.014","article-title":"Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure","volume":"45","author":"Mueller","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2014.08.012_b0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2014.08.012_b0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1124\/dmd.113.052415","article-title":"Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures","volume":"41","author":"Parmentier","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0185","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/dmd.105.007708","article-title":"Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating","volume":"34","author":"Richert","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1018916027099","article-title":"Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning","volume":"11","author":"Sawada","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2014.08.012_b0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.tiv.2014.08.012_b0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0887-2333(02)00014-0","article-title":"Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration","volume":"16","author":"Seibert","year":"2002","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.08.012_b0205","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.08.012_b0220","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/es303505z","article-title":"Predicting fish acute toxicity using a fish gill cell line-based toxicity assay","volume":"47","author":"Tanneberger","year":"2013","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2014.08.012_b0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)32167-1","article-title":"Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver","volume":"214","author":"Tavoloni","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2014.08.012_b0230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-2952(82)90149-6","article-title":"Effect of chlorpromazine on isolated rat hepatocytes","volume":"31","author":"Tsao","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2014.08.012_b0235","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tiv.2009.03.008","article-title":"Functional expression, inhibition and induction of CYP enzymes in HepaRG cells","volume":"23","author":"Turpeinen","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.08.012_b0240","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/17425255.4.7.855","article-title":"Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism","volume":"4","author":"Tuschl","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2014.08.012_b0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cbi.2009.05.015","article-title":"Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies","volume":"181","author":"Tuschl","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2014.08.012_b0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/alcalc\/agg099","article-title":"Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate","volume":"38","author":"Van Pelt","year":"2003","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.tiv.2014.08.012_b0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-006-0437-9","article-title":"Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein","volume":"187","author":"Wang","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tiv.2014.08.012_b0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","article-title":"Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress","volume":"79","author":"Wilmes","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1016\/j.tiv.2014.08.012_b0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0024-3205(00)00613-5","article-title":"Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes","volume":"67","author":"Yoshii","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2014.08.012_b0270","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.biomaterials.2010.09.064","article-title":"A robust high-throughput sandwich cell-based drug screening platform","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.tiv.2014.08.012_b0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:25:13Z","timestamp":1747146313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0887233314002021"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.08.012","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}